Elson M L
J Dermatol Surg Oncol. 1993 Feb;19(2):165-8; discussion 170. doi: 10.1111/j.1524-4725.1993.tb03448.x.
The media and litigation in the United States have alleged a link between the use of injectable bovine collagen and the development of autoimmune disease, specifically dermatomyositis/polymyositis.
To present the scientific and epidemiologic data with regard to this issue.
Literature was reviewed as well as reports to Collagen Corporation and the litigation.
After review of the literature and review of data currently available to Collagen Corporation, no link can be established at this time between collagen injectable material and autoimmune disease, specifically dermatomyositis/polymyositis.
There are no epidemiologic or scientific data to support the alleged link in the media and litigation between injectable bovine collagen material and dermatomyositis/polymyositis.
美国的媒体和诉讼称注射用牛胶原蛋白的使用与自身免疫性疾病的发生之间存在关联，特别是皮肌炎/多肌炎。
介绍关于此问题的科学和流行病学数据。
查阅了文献以及向胶原蛋白公司提交的报告和诉讼材料。
在查阅文献并审查了胶原蛋白公司目前可获得的数据后，目前无法确定注射用胶原蛋白材料与自身免疫性疾病，特别是皮肌炎/多肌炎之间存在关联。
没有流行病学或科学数据支持媒体和诉讼中所称的注射用牛胶原蛋白材料与皮肌炎/多肌炎之间的关联。
